189 related articles for article (PubMed ID: 36879169)
21. Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction.
Meinzer U; Barreau F; Esmiol-Welterlin S; Jung C; Villard C; Léger T; Ben-Mkaddem S; Berrebi D; Dussaillant M; Alnabhani Z; Roy M; Bonacorsi S; Wolf-Watz H; Perroy J; Ollendorff V; Hugot JP
Cell Host Microbe; 2012 Apr; 11(4):337-51. PubMed ID: 22520462
[TBL] [Abstract][Full Text] [Related]
22. The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches.
Logsdon LK; Mecsas J
Infect Immun; 2006 Mar; 74(3):1516-27. PubMed ID: 16495522
[TBL] [Abstract][Full Text] [Related]
23. Identification of pathogenic strains within serogroups of Yersinia pseudotuberculosis and the presence of non-pathogenic strains isolated from animals and the environment.
Nagano T; Kiyohara T; Suzuki K; Tsubokura M; Otsuki K
J Vet Med Sci; 1997 Mar; 59(3):153-8. PubMed ID: 9101473
[TBL] [Abstract][Full Text] [Related]
24. Sequencing of virulence genes shows limited genetic variability in Yersinia pseudotuberculosis.
Palonen E; Kangas S; Somervuo P; Lindström M; Fredriksson-Ahomaa M; Skurnik M; Korkeala H
Foodborne Pathog Dis; 2013 Jan; 10(1):21-7. PubMed ID: 23153288
[TBL] [Abstract][Full Text] [Related]
25. Spatiotemporal Variations in Growth Rate and Virulence Plasmid Copy Number during
Schneiders S; Hechard T; Edgren T; Avican K; Fällman M; Fahlgren A; Wang H
Infect Immun; 2021 Mar; 89(4):. PubMed ID: 33495272
[TBL] [Abstract][Full Text] [Related]
26. RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense.
Peterson LW; Philip NH; DeLaney A; Wynosky-Dolfi MA; Asklof K; Gray F; Choa R; Bjanes E; Buza EL; Hu B; Dillon CP; Green DR; Berger SB; Gough PJ; Bertin J; Brodsky IE
J Exp Med; 2017 Nov; 214(11):3171-3182. PubMed ID: 28855241
[TBL] [Abstract][Full Text] [Related]
27. The cytotoxic protein YopE of Yersinia obstructs the primary host defence.
Rosqvist R; Forsberg A; Rimpiläinen M; Bergman T; Wolf-Watz H
Mol Microbiol; 1990 Apr; 4(4):657-67. PubMed ID: 2191183
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of a novel Toll/interleukin-1 receptor (TIR)-domain containing virulence protein of Y. pseudotuberculosis among Far East scarlet-like fever serotype I strains.
Nörenberg D; Wieser A; Magistro G; Hoffmann C; Meyer C; Messerer M; Schubert S
Int J Med Microbiol; 2013 Dec; 303(8):583-94. PubMed ID: 24018301
[TBL] [Abstract][Full Text] [Related]
29. Global discovery of small RNAs in Yersinia pseudotuberculosis identifies Yersinia-specific small, noncoding RNAs required for virulence.
Koo JT; Alleyne TM; Schiano CA; Jafari N; Lathem WW
Proc Natl Acad Sci U S A; 2011 Sep; 108(37):E709-17. PubMed ID: 21876162
[TBL] [Abstract][Full Text] [Related]
30. Defective innate cell response and lymph node infiltration specify Yersinia pestis infection.
Guinet F; Avé P; Jones L; Huerre M; Carniel E
PLoS One; 2008 Feb; 3(2):e1688. PubMed ID: 18301765
[TBL] [Abstract][Full Text] [Related]
31. Tissue dual RNA-seq allows fast discovery of infection-specific functions and riboregulators shaping host-pathogen transcriptomes.
Nuss AM; Beckstette M; Pimenova M; Schmühl C; Opitz W; Pisano F; Heroven AK; Dersch P
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):E791-E800. PubMed ID: 28096329
[TBL] [Abstract][Full Text] [Related]
32. Increased plasmid copy number is essential for Yersinia T3SS function and virulence.
Wang H; Avican K; Fahlgren A; Erttmann SF; Nuss AM; Dersch P; Fallman M; Edgren T; Wolf-Watz H
Science; 2016 Jul; 353(6298):492-5. PubMed ID: 27365311
[TBL] [Abstract][Full Text] [Related]
33. The complete genome sequence of Yersinia pseudotuberculosis IP31758, the causative agent of Far East scarlet-like fever.
Eppinger M; Rosovitz MJ; Fricke WF; Rasko DA; Kokorina G; Fayolle C; Lindler LE; Carniel E; Ravel J
PLoS Genet; 2007 Aug; 3(8):e142. PubMed ID: 17784789
[TBL] [Abstract][Full Text] [Related]
34. A putative DNA adenine methyltransferase is involved in Yersinia pseudotuberculosis pathogenicity.
Pouillot F; Fayolle C; Carniel E
Microbiology (Reading); 2007 Aug; 153(Pt 8):2426-2434. PubMed ID: 17660407
[TBL] [Abstract][Full Text] [Related]
35. YPTB3816 of Yersinia pseudotuberculosis strain IP32953 is a virulence-related metallo-oligopeptidase.
Atas A; Seddon AM; Ford DC; Cooper IA; Wren BW; Oyston PC; Karlyshev AV
BMC Microbiol; 2016 Nov; 16(1):282. PubMed ID: 27887582
[TBL] [Abstract][Full Text] [Related]
36. Nod2 mediates susceptibility to Yersinia pseudotuberculosis in mice.
Meinzer U; Esmiol-Welterlin S; Barreau F; Berrebi D; Dussaillant M; Bonacorsi S; Chareyre F; Niwa-Kawakita M; Alberti C; Sterkers G; Villard C; Lesuffleur T; Peuchmaur M; Karin M; Eckmann L; Giovannini M; Ollendorff V; Wolf-Watz H; Hugot JP
PLoS One; 2008 Jul; 3(7):e2769. PubMed ID: 18648508
[TBL] [Abstract][Full Text] [Related]
37. In vivo-induced InvA-like autotransporters Ifp and InvC of Yersinia pseudotuberculosis promote interactions with intestinal epithelial cells and contribute to virulence.
Pisano F; Kochut A; Uliczka F; Geyer R; Stolz T; Thiermann T; Rohde M; Dersch P
Infect Immun; 2012 Mar; 80(3):1050-64. PubMed ID: 22158741
[TBL] [Abstract][Full Text] [Related]
38. Loss of CNFY toxin-induced inflammation drives Yersinia pseudotuberculosis into persistency.
Heine W; Beckstette M; Heroven AK; Thiemann S; Heise U; Nuss AM; Pisano F; Strowig T; Dersch P
PLoS Pathog; 2018 Feb; 14(2):e1006858. PubMed ID: 29390040
[TBL] [Abstract][Full Text] [Related]
39. IscR is essential for yersinia pseudotuberculosis type III secretion and virulence.
Miller HK; Kwuan L; Schwiesow L; Bernick DL; Mettert E; Ramirez HA; Ragle JM; Chan PP; Kiley PJ; Lowe TM; Auerbuch V
PLoS Pathog; 2014 Jun; 10(6):e1004194. PubMed ID: 24945271
[TBL] [Abstract][Full Text] [Related]
40. The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence.
Grabenstein JP; Marceau M; Pujol C; Simonet M; Bliska JB
Infect Immun; 2004 Sep; 72(9):4973-84. PubMed ID: 15321989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
